Bile acids activate YAP to promote liver carcinogenesis
Sayeepriyadarshini Anakk1, Manoj Bhosale2, Valentina A Schmidt3
1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, IL 61801, USA.
Abstract:
Elevated bile acid levels increase hepatocellular carcinoma by unknown mechanisms. Here, we show that mice with a severe defect in bile acid homeostasis due to the loss of the nuclear receptors FXR and SHP have enlarged livers, progenitor cell proliferation, and Yes-associated protein (YAP) activation and develop spontaneous liver tumorigenesis. This phenotype mirrors mice with loss of hippo kinases or overexpression of their downstream target, YAP. Bile acids act as upstream regulators of YAP via a pathway dependent on the induction of the scaffold protein IQGAP1. Patients with diverse biliary dysfunctions exhibit enhanced IQGAP1 and nuclear YAP expression. Our findings reveal an unexpected mechanism for bile acid regulation of liver growth and tumorigenesis via the Hippo pathway.
Related Concept Videos
Cirrhosis II: Pathophysiology
The Intrinsic Apoptotic Pathway
Bioactivation and Tissue Toxicity
Mutagenicity and Carcinogenicity
Induced Pluripotent Stem Cells
Somatic...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...


